ArriVent BioPharma (AVBP) Cash from Investing Activities (2025 - 2026)
ArriVent BioPharma's (AVBP) quarterly Cash from Investing Activities came in at $3.6 million in Q1 2026, down 90.27% year-on-year from $36.8 million in Q1 2025, and up 105.03% quarter-over-quarter from -$71.2 million in Q4 2025.
ArriVent BioPharma (AVBP) Cash from Investing Activities (2025 - 2026) Analysis & Trends
ArriVent BioPharma has disclosed Cash from Investing Activities across 2 years of filings, most recently posting $3.6 million for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $3.6 million, down 90.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$104.5 million (changed N/A YoY), and the FY2025 annual result was -$71.2 million, up 62.99% from the prior year.
- Cash from Investing Activities came in at $3.6 million for Q1 2026 at ArriVent BioPharma, up from -$71.2 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $36.8 million in Q1 2025 to a low of -$71.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 579,519.10 |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | 3.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58 Mn |
| Mar 31, 2026 | 3.58 Mn |
| Dec 31, 2025 | -71.20 Mn |
| Dec 31, 2025 | -71.20 Mn |
| Sep 30, 2025 | -50.76 Mn |
| Sep 30, 2025 | -50.76 Mn |
| Jun 30, 2025 | 13.91 Mn |
| Jun 30, 2025 | 13.91 Mn |
| Mar 31, 2025 | 36.82 Mn |
| Mar 31, 2025 | 36.82 Mn |